<< Back
Spasticity Management During the COVID-19 Pandemic (Recorded on 4/22/2020)
Please note that the views and opinions expressed within this activity are attributable to the panelists and are not formally endorsed by the AAPM&R. Several legislative, regulatory and reimbursement changes have occurred in recent weeks and are continuing to evolve as a result of the COVID-19 pandemic. The information provided reflects the understanding of the panelists at the time this session was recorded. Please refer to all currently approved guidelines and regulations for formal guidance.
Description
Physiatrists are at the forefront of spasticity management and need to have an in-depth understanding of spasticity and its impact on patients. Given the current environment and the inability to see patients, join this webinar discussion to hear how a few experts are managing their patients and assessing the advantages and disadvantages of all treatment options during this crisis.
Panelists include:
- Reza Farid, MD, FAAPMR
- Michael C. Munin, MD, FAAPMR
- Michael F. Saulino, MD, FAAPMR
- Andrea P. Toomer, MD, FAAPMR